144 related articles for article (PubMed ID: 18971625)
1. Characterization of the freeze sensitivity of a hepatitis B vaccine.
Chen D; Tyagi A; Carpenter J; Perkins S; Sylvester D; Guy M; Kristensen DD; Braun LJ
Hum Vaccin; 2009; 5(1):26-32. PubMed ID: 18971625
[TBL] [Abstract][Full Text] [Related]
2. Stability of an aluminum salt-adjuvanted protein D-conjugated pneumococcal vaccine after exposure to subzero temperatures.
Fortpied J; Wauters F; Rochart C; Hermand P; Hoet B; Moniotte N; Vojtek I
Hum Vaccin Immunother; 2018 May; 14(5):1243-1250. PubMed ID: 29337646
[TBL] [Abstract][Full Text] [Related]
3. Freeze-thaw stress of Alhydrogel ® alone is sufficient to reduce the immunogenicity of a recombinant hepatitis B vaccine containing native antigen.
Clapp T; Munks MW; Trivedi R; Kompella UB; Braun LJ
Vaccine; 2014 Jun; 32(30):3765-71. PubMed ID: 24856785
[TBL] [Abstract][Full Text] [Related]
4. Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvants.
Braun LJ; Tyagi A; Perkins S; Carpenter J; Sylvester D; Guy M; Kristensen D; Chen D
Vaccine; 2009 Jan; 27(1):72-9. PubMed ID: 18973782
[TBL] [Abstract][Full Text] [Related]
5. A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.
Li X; Thakkar SG; Ruwona TB; Williams RO; Cui Z
J Control Release; 2015 Apr; 204():38-50. PubMed ID: 25735896
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a thermostable hepatitis B vaccine formulation.
Braun LJ; Jezek J; Peterson S; Tyagi A; Perkins S; Sylvester D; Guy M; Lal M; Priddy S; Plzak H; Kristensen D; Chen D
Vaccine; 2009 Jul; 27(34):4609-14. PubMed ID: 19523912
[TBL] [Abstract][Full Text] [Related]
7. The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.
Thakkar SG; Ruwona TB; Williams RO; Cui Z
Hum Vaccin Immunother; 2017 Apr; 13(4):936-946. PubMed ID: 28051903
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B vaccine freezing in the Indonesian cold chain: evidence and solutions.
Nelson CM; Wibisono H; Purwanto H; Mansyur I; Moniaga V; Widjaya A
Bull World Health Organ; 2004 Feb; 82(2):99-105. PubMed ID: 15042231
[TBL] [Abstract][Full Text] [Related]
9. Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars.
Tonnis WF; Amorij JP; Vreeman MA; Frijlink HW; Kersten GF; Hinrichs WL
Eur J Pharm Sci; 2014 May; 55():36-45. PubMed ID: 24468629
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application.
Maa YF; Zhao L; Payne LG; Chen D
J Pharm Sci; 2003 Feb; 92(2):319-32. PubMed ID: 12532382
[TBL] [Abstract][Full Text] [Related]
11. Is freezing in the vaccine cold chain an ongoing issue? A literature review.
Hanson CM; George AM; Sawadogo A; Schreiber B
Vaccine; 2017 Apr; 35(17):2127-2133. PubMed ID: 28364920
[TBL] [Abstract][Full Text] [Related]
12. A freeze-stable formulation for DTwP and DTaP vaccines.
Xue H; Yang B; Kristensen DD; Chen D
Hum Vaccin Immunother; 2014; 10(12):3607-10. PubMed ID: 25668668
[TBL] [Abstract][Full Text] [Related]
13. Exposure to heat and freezing in the vaccine cold chain in Thailand.
Techathawat S; Varinsathien P; Rasdjarmrearnsook A; Tharmaphornpilas P
Vaccine; 2007 Jan; 25(7):1328-33. PubMed ID: 17157419
[TBL] [Abstract][Full Text] [Related]
14. A heat-stable hepatitis B vaccine formulation.
Jezek J; Chen D; Watson L; Crawford J; Perkins S; Tyagi A; Jones-Braun L
Hum Vaccin; 2009 Aug; 5(8):529-35. PubMed ID: 19556877
[TBL] [Abstract][Full Text] [Related]
15. Effect of freezing on recombinant hepatitis E vaccine.
Li K; Dong F; Gao F; Bian L; Sun S; Du R; Hu Y; Mao Q; Zheng H; Wu X; Liang Z
Hum Vaccin Immunother; 2020 Jul; 16(7):1545-1553. PubMed ID: 31809644
[TBL] [Abstract][Full Text] [Related]
16. Exposure of hepatitis B vaccine to freezing temperatures during transport to rural health centers in Mongolia.
Edstam JS; Dulmaa N; Tsendjav O; Dambasuren B; Densmaa B
Prev Med; 2004 Aug; 39(2):384-8. PubMed ID: 15226050
[TBL] [Abstract][Full Text] [Related]
17. Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles.
Diminsky D; Moav N; Gorecki M; Barenholz Y
Vaccine; 1999 Aug; 18(1-2):3-17. PubMed ID: 10501230
[TBL] [Abstract][Full Text] [Related]
18. Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method.
Chen D; Kapre S; Goel A; Suresh K; Beri S; Hickling J; Jensen J; Lal M; Preaud JM; Laforce M; Kristensen D
Vaccine; 2010 Jul; 28(31):5093-9. PubMed ID: 20478345
[TBL] [Abstract][Full Text] [Related]
19. Freeze-drying of plant tissue containing HBV surface antigen for the oral vaccine against hepatitis B.
Czyż M; Dembczyński R; Marecik R; Wojas-Turek J; Milczarek M; Pajtasz-Piasecka E; Wietrzyk J; Pniewski T
Biomed Res Int; 2014; 2014():485689. PubMed ID: 25371900
[TBL] [Abstract][Full Text] [Related]
20. Thin-Film Freeze-Drying Is a Viable Method to Convert Vaccines Containing Aluminum Salts from Liquid to Dry Powder.
Alzhrani RF; Xu H; Moon C; Suggs LJ; Williams RO; Cui Z
Methods Mol Biol; 2021; 2183():489-498. PubMed ID: 32959262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
